Profile data is unavailable for this security.
About the company
Bioventix plc is a United Kingdom-based company specializing in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, such as automated immunoassays used in blood testing. The antibodies created at the Company are generated in sheep and are of particular benefit where the target is present at low concentration and where conventional monoclonal or polyclonal antibodies have failed to produce a suitable reagent. It offers a portfolio of antibodies to customers for both commercial use and research and development purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The Company’s products include sheep monoclonal antibodies (SMAs), Pyrene (HOP-G) ELISA Kits, and Pyrene (HOP-G) Lateral Flow Kits. The Company supplies antibody products and services to the majority of multinational clinical diagnostics companies.
- Revenue in GBP (TTM)13.12m
- Net income in GBP7.58m
- Incorporated2003
- Employees16.00
- LocationBioventix PLC7 Romans Business Park, East StreetFARNHAM GU9 7SXUnited KingdomGBR
- Phone+44 12 5272 8001Fax+44 12 5272 8002
- Websitehttps://www.bioventix.com/
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Fusion Antibodies PLC | 1.60m | -1.47m |
| Sareum Holdings Plc | 0.00 | -4.44m |
| Arecor Therapeutics PLC | 5.06m | -8.10m |
| Poolbeg Pharma PLC | 0.00 | -5.71m |
| ImmuPharma PLC | 0.00 | -3.93m |
| hVIVO PLC | 51.28m | 5.28m |
| Skinbiotherapeutics PLC | 4.64m | -696.25k |
| Hemogenyx Pharmaceuticals PLC | 0.00 | -7.81m |
| 4Basebio PLC | 1.78m | -14.41m |
| Bioventix PLC | 13.12m | 7.58m |
| Scancell Holdings Plc | 4.71m | -5.51m |
| Faron Pharmaceuticals Oy | 0.00 | -26.87m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| Liontrust Investment Partners LLPas of 24 Oct 2025 | 571.00k | 10.93% |
| Sanford DeLand Asset Management Ltd.as of 24 Oct 2025 | 498.00k | 9.53% |
| Gresham House Asset Management Ltd. (Investment Management)as of 03 Mar 2025 | 421.00k | 8.06% |
| Schroder Investment Management Ltd.as of 24 Oct 2025 | 285.00k | 5.46% |
| Investec Wealth & Investment Ltd.as of 24 Oct 2025 | 269.00k | 5.15% |
| Raymond James Wealth Management Ltd. (Investment Management)as of 24 Oct 2025 | 264.00k | 5.05% |
| Santander Asset Management UK Ltd.as of 03 Mar 2025 | 213.00k | 4.08% |
| Rathbones Investment Management Ltd.as of 24 Oct 2025 | 187.00k | 3.58% |
| Danske Bank A/S (Investment Management)as of 30 Nov 2025 | 99.91k | 1.91% |
| Hargreaves Lansdown Fund Managers Ltd.as of 03 Mar 2025 | 88.00k | 1.68% |
